Pursuant to Section 307B.4, Title 25, Oklahoma Statutes, consider convening in executive session to discuss an action relating to litigation against the manufacturers and distributors of opioids in an effort to hold them accountable for their marketing practices alleged to have caused public nuisance and monetary damages suffered by municipalities, and if necessary take action in open session with regard to a claim asserted by the City of Lawton as deemed appropriate. Specifically, discuss the City’s pending litigation as part of the In Re: National Prescription Opiate Litigation MDL No. 2804, including the impact of the following subsequent bankruptcy filings: Case No. 19-23649, Chapter 11, filed in the U.S. Bankruptcy Court Southern District of New York, styled In Re: Purdue Pharma L.P., et al., Debtors, on the City’s litigation; and Case No. 20-12522, Chapter 11, filed in the United States Bankruptcy Court for the District of Delaware, styled In Re: Mallinckrodt PLC, et al., Debtors, on the City’s litigation; and if necessary, take action in open session.

Committee

City Council

Introduced

June 29, 2021

On agenda

July 13, 2021